To explore whether SENP3/5 might be exploited to target CDK6, we used the pancreatic cancer cell line BxPC3 as a high CDK6 model system that concomitantly exhibits low CDK4 expression and additionally lacks functional p53 (Fig. 8a). This evidence concerns the gene CDK4 and familial pancreatic carcinoma.